Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.4K
The Tumor Microenvironment02:17

The Tumor Microenvironment

6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Discovery of Small-Molecule Antagonists of PHF1 and 19 Demonstrates the Ligandability of PRC2 Accessory Proteins.

ACS bio & med chem Au·2026
Same author

Free-floating long-term vascularized mesenchymal organoids.

iScience·2026
Same author

Correction: Longitudinal single-cell analysis reveals treatment-resistant stem and mast cells with potential treatments for pediatric AML.

Leukemia·2025
Same author

Longitudinal single-cell analysis reveals treatment-resistant stem and mast cells with potential treatments for pediatric AML.

Leukemia·2025
Same author

iMer, a naturally occurring MERTK splice variant, binds to GAS6 to decrease platelet activation and thrombus formation.

Blood vessels, thrombosis & hemostasis·2025
Same author

<i>Drosophila</i> Males Differentially Express Small Proteins Regulating Stem Cell Division Frequency in Response to Mating.

Journal of developmental biology·2025

相关实验视频

Updated: Jun 14, 2025

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
12:03

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

12.4K

默特克是尤文肉瘤的潜在治疗目标.

Sherri K Smart1,2, Tsz Y Yeung1,2, M Olivia Santos3

  • 1Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA 30322, USA.

Cancers
|August 29, 2024
PubMed
概括

MER原瘤原型氨酸激酶 (MERTK) 是尤文肉瘤 (EWS) 的一个有前途的标. 用MRX-2843抑制MERTK显示出强大的抗瘤活性,并可能改善EWS患者的结果.

关键词:
在BCL-2中.在BCL-XL之间.这就是MERTK的意思.在 MRX-284343 里面.伊温格肉瘤 (Ewing Sarcoma) 是一种癌症.小分子抑制剂小分子抑制剂

更多相关视频

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

3.6K
Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
09:58

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

2.7K

相关实验视频

Last Updated: Jun 14, 2025

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
12:03

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

12.4K
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

3.6K
Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
09:58

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

2.7K

科学领域:

  • 在瘤学瘤学.
  • 分子生物学分子生物学
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 晚期或复发的尤文肉瘤 (EWS) 结果不佳,治疗选择有限.
  • 目前的EWS治疗有显著的副作用.
  • MER原基因氨酸激酶 (MERTK) 与瘤细胞存活率和治疗耐药性有关.

研究的目的:

  • 调查MERTK作为EWS中的治疗点.
  • 在EWS模型中评估MRX-2843,一种MERTK抑制剂的疗效.
  • 探索涉及MRX-2843.3的组合疗法.

主要方法:

  • 在EWS细胞系和患者样本中评估MERTK表达.
  • 利用基于CRISPR的图书馆屏幕来确定EWS中的MERTK依赖性.
  • 用MRX-2843处理了EWS细胞,并评估了MERTK信号传递和细胞活力.
  • 与MRX-2843和BCL-2抑制剂 (venetoclax,navitoclax) 进行测试的组合疗法.

主要成果:

  • 在EWS细胞系和患者样本中,MERTK被普遍表达.
  • EWS细胞表现出对MERTK的显著依赖.
  • MRX-2843强烈抑制了MERTK信号传递,并表现出强烈的抗瘤活性 (IC50:178-297 nM).
  • 结合的MRX-2843和BCL-2抑制剂显示了增强的治疗效果.

结论:

  • 对于EWS来说,MERTK是一个可行的治疗点.
  • MRX-2843显示出显著的反EWS活动.
  • 使用MRX-2843和BCL-2抑制剂的联合治疗需要进一步研究EWS治疗.